Amgen’s Third Quarter 2012 Revenues Increased 10 Percent to $4.3 Billion and Adjusted Earnings Per Share (EPS) Increased 19 Percent to $1.67

Amgen (AMGN) today announced financial results for the third quarter of 2012. Key results for the quarter include: Total revenues increased 10 percent to $4,319 million, with 8 percent product sales growth driven by strong performance across the portfolio.